mTOR inhibitor augments the antitumor effect of p53-expressing oncolytic adenovirus in human neuroblastoma cells

被引：0
|
作者：
Tanimoto, Terutaka [1 ]
Tazawa, Hiroshi [1 ]
Noso, Hiroshi [1 ]
Tani, Morimichi [1 ]
Oyama, Takanori [1 ]
Urata, Yasuo [2 ]
Kagawa, Shunsuke [1 ]
Noda, Takuo [1 ]
Fujiwara, Toshiyoshi [1 ]
机构：
[1] Okayama Univ, Okayama, Japan
[2] Oncolys Biopharma Inc, Okayama, Japan
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-3177
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3177
引用
收藏
页数：2
相关论文
共 50 条
  • [21] p53-mediated apoptotic signaling overcomes the resistance to oncolytic adenovirus in human osteosarcoma cells
    Hasel, Joe
    Sasaki, Tsuyoshi
    Tazawa, Hiroshi
    Hashimoto, Yuuri
    Kunisada, Toshiyuki
    Urata, Yasuo
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    CANCER RESEARCH, 2012, 72
  • [22] ANTITUMOR EFFECT OF TELOMERASE-SPECIFIC ONCOLYTIC ADENOVIRUS ON HUMAN BONE AND SOFT TISSUE SARCOMA CELLS
    Tazawa, Hiroshi
    Sasaki, Tsuyoshi
    Hasei, Jo
    Hashimoto, Yuuri
    Urata, Yasuo
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    JOURNAL OF GENE MEDICINE, 2014, 16 (7-8): : 261 - 262
  • [23] Antitumor Effect of Saikosaponin A on Human Neuroblastoma Cells
    Cheng, Tan
    Ying, Muying
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [24] Mutant p53-Expressing Cells Undergo Necroptosis via Cell Competition with the Neighboring Normal Epithelial Cells
    Watanabe, Hirotaka
    Ishibashi, Kojiro
    Mano, Hiroki
    Kitamoto, Sho
    Sato, Nanami
    Hoshiba, Kazuya
    Kato, Mugihiko
    Matsuzawa, Fumihiko
    Takeuchi, Yasuto
    Shirai, Takanobu
    Ishikawa, Susumu
    Morioka, Yuka
    Imagawa, Toshiaki
    Sakaguchi, Kazuyasu
    Yonezawa, Suguru
    Kon, Shunsuke
    Fujita, Yasuyuki
    CELL REPORTS, 2018, 23 (13): : 3721 - 3729
  • [25] Silencing of AURKA augments the antitumor efficacy of the AURKA inhibitor MLN8237 on neuroblastoma cells
    Yan Yang
    Lili Ding
    Qi Zhou
    Li Fen
    Yuhua Cao
    Junjie Sun
    Xuefeng Zhou
    Aiguo Liu
    Cancer Cell International, 20
  • [26] miR-3132 induces TRAIL and cell death in mutant p53-expressing cancer cells
    Lulla, Amriti R.
    Einarson, Margret B.
    Zhou, Yan
    Lev, Avital
    Dicker, David T.
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2018, 78 (13)
  • [27] Silencing of AURKA augments the antitumor efficacy of the AURKA inhibitor MLN8237 on neuroblastoma cells
    Yang, Yan
    Ding, Lili
    Zhou, Qi
    Fen, Li
    Cao, Yuhua
    Sun, Junjie
    Zhou, Xuefeng
    Liu, Aiguo
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [28] Lack of p53 Augments Antitumor Functions in Cytolytic T Cells
    Banerjee, Anirban
    Thyagarajan, Krishnamurthy
    Chatterjee, Shilpak
    Chakraborty, Paramita
    Kesarwani, Pravin
    Soloshchenko, Myroslawa
    Al-Hommrani, Mazen
    Andrijauskaite, Kristina
    Moxley, Kelly
    Janakiraman, Harinarayanan
    Scheffel, Matthew J.
    Helke, Kristi
    Armenson, Kent
    Palanisamy, Viswanathan
    Rubinstein, Mark P.
    Mayer, Elizabeth-Garrett
    Cole, David J.
    Paulos, Chrystal M.
    Voelkel-Johnson, Christina
    Nishimura, Michael I.
    Mehrotra, Shikhar
    CANCER RESEARCH, 2016, 76 (18) : 5229 - 5240
  • [29] Differentiation of human neuroblastoma cells toward the osteogenic lineage by mTOR inhibitor
    A Carpentieri
    E Cozzoli
    M Scimeca
    E Bonanno
    A M Sardanelli
    A Gambacurta
    Cell Death & Disease, 2015, 6 : e1974 - e1974
  • [30] Differentiation of human neuroblastoma cells toward the osteogenic lineage by mTOR inhibitor
    Carpentieri, A.
    Cozzoli, E.
    Scimeca, M.
    Bonanno, E.
    Sardanelli, A. M.
    Gambacurta, A.
    CELL DEATH & DISEASE, 2015, 6 : e1974 - e1974
12345